CPC A61K 31/495 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 31/166 (2013.01); A61K 31/664 (2013.01); A61K 45/06 (2013.01); A61P 27/02 (2018.01); A61P 35/00 (2018.01); C07C 233/78 (2013.01); C07D 241/04 (2013.01); C07F 9/222 (2013.01)] | 8 Claims |
1. A compound or a pharmaceutically acceptable salt, solvate, hydrate, cocrystal, or prodrug thereof, selected from Compound 1, Compound 2, Compound 3, and Compound 4:
|